• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞中Cbl-b介导的泛素化对PI3K的非蛋白酶解依赖性调控

Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.

作者信息

Fang D, Liu Y C

机构信息

Division of Cell Biology, La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, San Diego, CA 92121, USA.

出版信息

Nat Immunol. 2001 Sep;2(9):870-5. doi: 10.1038/ni0901-870.

DOI:10.1038/ni0901-870
PMID:11526404
Abstract

Cbl-b, a ring-type E3 ubiquitin protein ligase, is implicated in setting the threshold of T lymphocyte activation. The p85 regulatory subunit of phosphatidylinositol 3 kinase (PI3K) was identified as a substrate for Cbl-b. We have shown that Cbl-b negatively regulated p85 in a proteolysis-independent manner. Cbl-b is involved in the recruitment of p85 to CD28 and T cell antigen receptor zeta through its E3 ubiquitin ligase activity. The enhanced activation of Cbl-b(-/-) T cells was suppressed by the inhibition of PI3K. The results suggest a proteolysis-independent function for Cbl-b in the modification of protein recruitment.

摘要

Cbl-b是一种环状E3泛素蛋白连接酶,与设定T淋巴细胞激活阈值有关。磷脂酰肌醇3激酶(PI3K)的p85调节亚基被确定为Cbl-b的底物。我们已经表明,Cbl-b以不依赖蛋白水解的方式对p85进行负调控。Cbl-b通过其E3泛素连接酶活性参与将p85募集到CD28和T细胞抗原受体ζ。PI3K的抑制可抑制Cbl-b基因敲除(Cbl-b(-/-))T细胞的增强激活。结果表明Cbl-b在蛋白质募集修饰中具有不依赖蛋白水解的功能。

相似文献

1
Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.T细胞中Cbl-b介导的泛素化对PI3K的非蛋白酶解依赖性调控
Nat Immunol. 2001 Sep;2(9):870-5. doi: 10.1038/ni0901-870.
2
Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.Cbl-b是一种RING型E3泛素连接酶,可使T细胞中的磷脂酰肌醇3激酶发生泛素化。
J Biol Chem. 2001 Feb 16;276(7):4872-8. doi: 10.1074/jbc.M008901200. Epub 2000 Nov 21.
3
Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.前沿:通过靶向Cbl-b进行泛素化,CD28共刺激对T细胞激活阈值的调控
J Immunol. 2002 Sep 1;169(5):2236-40. doi: 10.4049/jimmunol.169.5.2236.
4
Cbl-b regulates the CD28 dependence of T-cell activation.Cbl-b调节T细胞活化对CD28的依赖性。
Nature. 2000 Jan 13;403(6766):216-20. doi: 10.1038/35003235.
5
E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.E3 泛素连接酶 Cbl-b 通过 Nedd4 在 T 细胞中调节 Pten,而不依赖其泛素连接酶活性。
Cell Rep. 2012 May 31;1(5):472-82. doi: 10.1016/j.celrep.2012.04.008.
6
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.分子衔接蛋白Cbl-b对淋巴细胞活化和自身免疫的负调控
Nature. 2000 Jan 13;403(6766):211-6. doi: 10.1038/35003228.
7
T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.T细胞受体诱导的核因子κB激活受到E3泛素连接酶Cbl-b的负调控。
Mol Cell Biol. 2008 Apr;28(7):2470-80. doi: 10.1128/MCB.01505-07. Epub 2008 Jan 28.
8
Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells.Cbl-b是T细胞中受体聚集和脂筏聚集的负调节因子。
Immunity. 2000 Oct;13(4):463-73. doi: 10.1016/s1074-7613(00)00046-7.
9
PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.蛋白激酶C-θ通过将Cbl-b靶向泛素化和降解来调节T细胞反应的强度。
Sci Signal. 2009 Jun 23;2(76):ra30. doi: 10.1126/scisignal.2000046.
10
Lymphocyte signaling: Cbl sets the threshold for autoimmunity.淋巴细胞信号传导:Cbl设定自身免疫的阈值。
Curr Biol. 2000 May 4;10(9):R344-7. doi: 10.1016/s0960-9822(00)00463-2.

引用本文的文献

1
Cbl-b inhibitor NX-1607 activates MAPK/ERK signaling pathway and enhances T-cell activation.Cbl-b抑制剂NX-1607激活丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)信号通路并增强T细胞活化。
J Immunother Cancer. 2025 May 30;13(5):e011180. doi: 10.1136/jitc-2024-011180.
2
Mechanisms of Cbl-Mediated Ubiquitination of Proteins in T and Natural Killer Cells and Effects on Immune Cell Functions.Cbl介导的T细胞和自然杀伤细胞中蛋白质泛素化的机制及其对免疫细胞功能的影响。
Life (Basel). 2024 Dec 3;14(12):1592. doi: 10.3390/life14121592.
3
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells.
抑制 Cbl-b 可恢复人肿瘤内 NK 细胞的效应功能。
J Immunother Cancer. 2024 Nov 17;12(11):e009860. doi: 10.1136/jitc-2024-009860.
4
Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies.2 型糖尿病发病机制中的分子方面及可能的预防和补充治疗。
Int J Mol Sci. 2024 Aug 22;25(16):9113. doi: 10.3390/ijms25169113.
5
Non-catalytic role of phosphoinositide 3-kinase in mesenchymal cell migration through non-canonical induction of p85β/AP2-mediated endocytosis.磷酸肌醇 3-激酶在非经典诱导 p85β/衔接蛋白 2 介导的内吞作用中的非催化作用对间充质细胞迁移的影响。
Nat Commun. 2024 Mar 23;15(1):2612. doi: 10.1038/s41467-024-46855-y.
6
Discovery of a Novel Benzodiazepine Series of Cbl-b Inhibitors for the Enhancement of Antitumor Immunity.发现用于增强抗肿瘤免疫力的新型苯二氮䓬类Cbl-b抑制剂系列
ACS Med Chem Lett. 2023 Nov 17;14(12):1848-1856. doi: 10.1021/acsmedchemlett.3c00439. eCollection 2023 Dec 14.
7
Small molecule inhibitors for cancer immunotherapy and associated biomarkers - the current status.小分子抑制剂在癌症免疫治疗及相关生物标志物中的应用现状。
Front Immunol. 2023 Oct 31;14:1297175. doi: 10.3389/fimmu.2023.1297175. eCollection 2023.
8
Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response.处于突变、癌症、靶向治疗和免疫反应交叉点的蛋白激酶C
Biology (Basel). 2023 Jul 26;12(8):1047. doi: 10.3390/biology12081047.
9
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.T 细胞受体(TCR)信号的负性细胞内调节剂作为潜在的抗肿瘤免疫治疗靶点。
J Immunother Cancer. 2023 May;11(5). doi: 10.1136/jitc-2022-005845.
10
E3-ubiquitin ligases and recent progress in osteoimmunology.E3 泛素连接酶与骨免疫学的最新进展。
Front Immunol. 2023 Feb 23;14:1120710. doi: 10.3389/fimmu.2023.1120710. eCollection 2023.